CHEMOTHERAPEUTIC AGENTS IN CANCER TREATMENT

Abstract

An early diagnosis and surgical extirpation of the tumor prior to metastatic invasion of other tissues is the essential fact and condition of cancer treatment. However, the apparent beneficial therapeutic and palliative effects of various types Of radiation therapy should also always kept in mind. The anticancer drugs which are being extensively investigated in laboratory and clinical research levels are usually being considered in cancer cases where both Surgical and radiation therapies have already failed or cancer J shown general dissemination. For this reason, the owerall results of cancer chemotherapy are not satisfactorily bright as yet. On the other hand, occasional hopeful curative and very often beneficial palliative effects of this therapy have been repeatedly reported and cannot be negletted. Furthermore, a confortable prolongation of life and the subsidence or disappearence of the patients suffering caused by large tumor infiltrations could be achieved by cancer chemotherapy and this is considered as one of the very important assets of treatment. In this paper the recent relevant medical literature related to this subject have been reviewed and it is intended to provide an up to date and concise information on anticancer agents, especially the ones which are accepted and being videly used clinically for the treatment of cancer.

Keywords

• cancer treatment
• chemotherapy
• cancer

KANSER TEDAVİSİNDE KEMOTERAPÖTiK AJANLAR

Abstract

Kanser tedavisinde ilk şart erken teşhis ve tümörün metastaz yapmadan cerrahi olarak çıkarılması olsa da, birçok vakada çeşitli radyasyon tedavilerinin bariz yararlı etkilerini de göz önünde bulundurmak gerekir. Birçok çalışmanın konusu olan antikanser ajanlar özellikle cerrahi ve radyasyon tedavileriyle sonuç alınamayan veya yaygın olarak yayılmış kanser türlerinde kullanılmaktadır ve kanser kemoterapisinde elde edilen sonuçlar her zaman tatmin edici olmamaktadır. Mamamif, bu ilaçlarla, bazen iyi sonuçlar elde edilir, nadir de olsa, ve çoğunlukla hafifletici, bazen de iyileştirici. Ayrıca, hastalara değişik sürelerle antikanser ilaçlarıyla yaşama şansı verilmesi ve ameliyat edilemez yaygın tümörlerde geniş yayılımların neden olduğu sıkıntıların giderilmesi veya hafifletilmesi de tedavide önemli bir değer taşır. Bu makalede, konuyla ilgili en son tıbbi gelişmeleri gözden geçiriyoruz.

Keywords

• kanser tedavisi
• kemoterapi
• kanser

References

1. 1 — m•TOCK, F. E. : Newer Anticancer Agents. M. Olin. North America 48: 501, 1964.
2. 2 — KARNOFSKY, D. cr..tFFORD, G. O. Selection of Antåcancer drugs for inclusion In Memorial Hospital Formulary. M. Clin. North America,50 : 857i 1966.
3. 3 — HOLZÐR, H. : Action of alkylattng substances on glycolysls. Chemotherapy of Cancer, Plattner, Editor, Elvesfer, Inndon 1964. S. 44
4. 4 — GOLDTHWAIT D. A. • Nucleic acids and cancer. Am. J. Med29 : 1034, 1960.
5. 5 — KARNOFSKY, D. : Chemotherapy of cancer and its present position in the management of neoplastic diseases. Chemotherapy of cancer, Plattner, Editor, Elsevier, London, 1964. S. 3
6. 6 — GELLER, W. : Hodgkin'e Disease. M. Clln. North America, 50 : 819,1964
7. 7 — BLOOM, H. J., WAI-LACE, D. M. : Hermones and the kidney. Brit M. J. 2 : 476, 1967.
8. 8 BOESEN, E. ET AL. : Clinical results with chlorambucll, melphalan, and 1,6 Dlemesylmannltol. Chemotherapy of cancer, Plattner, Editor, Elsevier, London, 1964, S. 51

9. 9 KAUFMAN, R. J. : Management of Advanced Ovarian carcinoma. M. Clin. North America, 50 : 845, 1966.
10. 10 — ESCHER, C. G. KAUFMAN J. R. : Current views on Management of Metasatic Mammary Carcinoma M. Clin. North America, 45 : 613, 1961.
11. 11 D. V., MEYER, O. : Response to chlorambucil in macroglobulinemla. JAMA. 183 : 40, 1963.
12. 12 — SULLIVAN R. D, MILLER, E. : Antimetabolite-metaboltte combination cancer chemotherapy. Cancer, 12 : 1248, 1959.
13. 13 — GERI-IA-RTZ, H. : Clinial results with cyclophosphamide and trisethylene iminoqulnone. Chemotherapy of cancer Plattner, Editor, Elsevier, London 1964, s. 62
14. 14 -— GOLBEY B. : Medical Management of Advanced Lung Cancer. M. aan. North America, 45 : 627, 1961.
15. 15 — Lt, M. D. : Management of Chorlocafclnoma and related tumors of uterus and testis. M. Clin. Nort America, 45 : 661, 1961.
16. 16 — ELLISON R. R. : Clinical Aplication of the Pyrimidines. M. cun. North America, 45 : 677, 1961.
17. 17 A-NSFtELD, H. : Five years clinical experience with 5. Fluorouracil. JAMA. 181 : 295, 1962.
18. 18 — BRENMAÑ, M. J.. TALLEY W, DtEGO L. : Critical Analysis of 594. Cancer patients treated with 5-F1uorourac.11. Chemetherapy of Cancer Plattner, Editor, Elsevier, London, 1964. S. 118.
19. 19 HUGGtNS, C. : Principles of hormone therapy of cancer. Chemotherapy of Cancer Plattner, Editor, Elsevier, London, 1964, S. 181.
20. 20 — TAGNON, H. J. : Clinical results With hormones in disseminated mammary cancer. Plattner, Editor, Elsevier, London, 1964, S. 186
21. 21 — SYKES, M. : Management of Endometrial Cancer. Clin. North America, 50 : 833. 1966
22. 22 — KENNEDY, B. J. A. : Progestegon for treatment of advanced endometrial cancer JAMA. 184 : 758, 1963.
23. 23 — CASTELLANOS, H., FAiRQRtEVE, J. F., O'MORCHOE, P. J. : Corticotropln stimulation of urethral corniflcatåon, JAMA. 184 : 295, 1963.988 MüNiR TELATAR — ALİ T. IŞITMAN — FEVZİ RENDA
24. 24 — DANTET, G. C. : Adrenal suppresslon in disseminated carclnomes of the breast. New England J. Med- 269 : 1. 1963
25. 25 — OBRECHT, F. : Vinca alkaloids. Chemotherapy of cancer, Plattner, Editor, Elsevıer, London, 1964, S. 165
26. 26 —- BURCHENAL, J. H., PURPLE, J. R., BUCHOLZ, E. : Combination studies with methylglyoxol vincristine and its nalogues. Blood 20 : 808. 1962.
27. 27 — CARBONE, P. : Clinicaı St.udles wıth Vincrıstıne. Blood 21 : 640, 1963.
28. 28 — KEMS, Y., STRYCKMANS, R, LEBRUM, J. : Clirdcaı trıaı wıth mi,tomycin C in patents with solid tumors. Chemotherapy of cancer. Plattner, Edinor, Elsevier, London, 1964, S. 153
29. 29 SCHMİDT, G. : Preliminary report on combined. Chemothrpy wlth ml tomycin C and Cyclophosphamlde. Chemotherapy of Cancer, Plattner, Editor, Elsevier, London, 1964, S. 153
30. 30 -— MARTZ, G. : Clinical results with a methylhydrazlne derivatlve. Chemotherapy of cancer Plattner, Editor, Elsevler, London, 1964, S. 178
31. 31 -— DAVMS, A. : The üşe of cytotoxlc agents in surgery. Recent advances in Surgery, 3. 64-89, 6 ed, IÂttle Brown and company, Boston, 1964.
32. 32 — F.ORTNDR, G. : Factors İn the treatment of Melemoma, M. Clin. North Amcııca, 45 : 643, 1963
33. 33 BEAITİE, F. J. : Treatment of maligmant pleural effuslons by patrial pleurectomy. S. Clinı North Amerlca, 43 : 99, 1963.
34. 34 — GALTAN, D. A. : Nitrogen Mustard, chlorambucll and Busulphan. Che--motherapy. of cancer Plattner, Editor, Elsevler, London 1964, S.- 203
35. 35 — SOLOMON, S. P. : Cyclophosphamlde, A clinlcal sLudy, JAMA. 183 • 36 HYMAN,. C. B. Central nervous System Involvement by Leukemia in cıılldren. Bibod. 25, ı, 1965.